Skip to main content

Clinical Effectiveness Group

We are the Clinical Effectiveness Group at Queen Mary University of London.

We use data-driven research and tools to improve population health in North East London and beyond. More about us.


Following the Covid-19 pandemic, there has been an increase in neighbourhoods in North East London where fewer than 60% of children receive their first MMR vaccine on time. These 'hotspots' - at highest risk of a measles outbreak - are clustered in the region's poorest areas.

CEG's Clinical Effectiveness approach in North East London is featured in a new report on cardiovascular disease by The King’s Fund. The case study highlights CEG's actionable insight, measuring of equity, and the digital decision-support and review tools that make it easier for GPs to do the right thing.

CEG is providing intelligence to inform the logistics of the immunisation campaign and software tools to ease the burden for GPs. Read the news story, or visit our campaign page for information about our resources for GP practices.